© 2022 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
May 06, 2022
Steve R. Ommen, MD, leads a review of common mutations seen in hypertrophic cardiomyopathy and the role of biomarkers and genetic testing in HCM.
Martin S. Maron, MD, discusses the incidence and prevalence of hypertrophic cardiomyopathy and age of disease expression.
Family History of OSA Contributes to Pathogenesis of the Condition
Significant OSA Prevalence in Pediatric Patients with Pulmonary Hypertension
Severe Asthma Exacerbation Risk Reduced with Combined Albuterol-Budesonide